SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-24-004915
Filing Date
2024-07-17
Accepted
2024-07-17 16:58:35
Documents
1
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4075
  Complete submission text file 0001683168-24-004915.txt   5748
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Issuer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O PHARMACYTE BIOTECH INC. 23046 AVENIDA DE LE CORLOTA LAGUNA HILLS CA 10041-0099
Business Address
Abecassis Michael M (Reporting) CIK: 0001879281 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40699 | Film No.: 241122805